GlassScriptPhysician profile
Adam Khan
NPI 1376956953
$10,850.56
in general payments reported to CMS, 2019-2025
17 companies · $4,124 in 2025
The $4,124 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $5,184 · 2024: $1,397 · 2025: $4,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,058 · Consulting Fee: $3,400 · Food and Beverage: $2,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,058.03 |
| Consulting Fee | $3,400.00 |
| Food and Beverage | $2,247.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ischemaview, INC. | $3,400.00 | 2025 | |
| Medtronic, INC. | $2,633.12 | 2022-2025 | Clydesdale Ptc Spinal System, Pipeline, Mazor X System |
| Silk Road Medical, INC. | $1,417.68 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Microvention, INC. | $1,382.00 | 2023 | Web Aneurysm Embolization System |
| Si-Bone, INC. | $1,101.49 | 2023-2024 | |
| Integra Lifesciences Corporation | $160.49 | 2024-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Medical Device Business Services, INC. | $147.59 | 2025 | Velys |
| Penumbra, INC. | $143.37 | 2024 | Penumbra System |
| Kuros Biosciences USA, INC | $138.16 | 2023 | |
| Kaneka Medical America LLC | $116.57 | 2025 | Apheresis Machine |
| Getinge USA Sales, LLC | $55.59 | 2023-2024 | Icast, Flixene |
| Ethicon US, LLC | $36.09 | 2025 | Vistaseal, Surgicel Nu-Knit, Prolene |
| Hemosonics LLC | $29.41 | 2023 | Quantra Qplus System |
| Depuy Synthes Sales INC. | $29.02 | 2024 | Emboguard, Embotrap |
| Stryker Corporation | $24.69 | 2024 | Target |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.26 | 2023 | Ranger |
| Qapel Medical INC | $13.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.